120 related articles for article (PubMed ID: 29673061)
21. Facing the new IVD Regulation 2017/746: Contract Research Organizations (CROs), key partners of IVDs manufacturers for compliance.
Kali S; Puisney C; Delalande ML; Franc G; Buisson C; Barradeau S
Clin Chem Lab Med; 2024 Apr; ():. PubMed ID: 38602283
[No Abstract] [Full Text] [Related]
22. Extracellular matrix hydrogel derived from decellularized tissues enables endodermal organoid culture.
Giobbe GG; Crowley C; Luni C; Campinoti S; Khedr M; Kretzschmar K; De Santis MM; Zambaiti E; Michielin F; Meran L; Hu Q; van Son G; Urbani L; Manfredi A; Giomo M; Eaton S; Cacchiarelli D; Li VSW; Clevers H; Bonfanti P; Elvassore N; De Coppi P
Nat Commun; 2019 Dec; 10(1):5658. PubMed ID: 31827102
[TBL] [Abstract][Full Text] [Related]
23. Cell-based strategies for IVD repair: clinical progress and translational obstacles.
Binch ALA; Fitzgerald JC; Growney EA; Barry F
Nat Rev Rheumatol; 2021 Mar; 17(3):158-175. PubMed ID: 33526926
[TBL] [Abstract][Full Text] [Related]
24. Decellularised nucleus pulposus as a potential biologic scaffold for disc tissue engineering.
Xu J; Liu S; Wang S; Qiu P; Chen P; Lin X; Fang X
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():1213-1225. PubMed ID: 30889657
[TBL] [Abstract][Full Text] [Related]
25. Injectable decellularized nucleus pulposus-based cell delivery system for differentiation of adipose-derived stem cells and nucleus pulposus regeneration.
Zhou X; Wang J; Huang X; Fang W; Tao Y; Zhao T; Liang C; Hua J; Chen Q; Li F
Acta Biomater; 2018 Nov; 81():115-128. PubMed ID: 30267879
[TBL] [Abstract][Full Text] [Related]
26. Decellularization of the mouse ovary: comparison of different scaffold generation protocols for future ovarian bioengineering.
Alshaikh AB; Padma AM; Dehlin M; Akouri R; Song MJ; Brännström M; Hellström M
J Ovarian Res; 2019 Jun; 12(1):58. PubMed ID: 31228949
[TBL] [Abstract][Full Text] [Related]
27. Decellularized nucleus pulposus matrix/chitosan hybrid hydrogel combined with nucleus pulposus stem cells and GDF5-loaded microspheres for intervertebral disc degeneration prevention.
Ma T; Liu C; Zhao Q; Zhang Y; Xiao L
Mol Med; 2024 Jan; 30(1):7. PubMed ID: 38200442
[TBL] [Abstract][Full Text] [Related]
28. Decellularized extracellular matrix biomaterials for regenerative therapies: Advances, challenges and clinical prospects.
Golebiowska AA; Intravaia JT; Sathe VM; Kumbar SG; Nukavarapu SP
Bioact Mater; 2024 Feb; 32():98-123. PubMed ID: 37927899
[TBL] [Abstract][Full Text] [Related]
29. Decellularized matrix for repairing intervertebral disc degeneration: Fabrication methods, applications and animal models.
Qian H; He L; Ye Z; Wei Z; Ao J
Mater Today Bio; 2023 Feb; 18():100523. PubMed ID: 36590980
[TBL] [Abstract][Full Text] [Related]
30. Development of 2-D and 3-D culture platforms derived from decellularized nucleus pulposus.
Herrera Quijano MA; Sharma N; Morissette Martin P; Séguin CA; Flynn LE
Front Bioeng Biotechnol; 2022; 10():937239. PubMed ID: 36237211
[TBL] [Abstract][Full Text] [Related]
31. Extracellular matrix in intervertebral disc: basic and translational implications.
Zhang S; Liu W; Chen S; Wang B; Wang P; Hu B; Lv X; Shao Z
Cell Tissue Res; 2022 Oct; 390(1):1-22. PubMed ID: 35792910
[TBL] [Abstract][Full Text] [Related]
32. Injectable decellularized nucleus pulposus tissue exhibits neuroinhibitory properties.
Piening LM; Lillyman DJ; Lee FS; Lozano AM; Miles JR; Wachs RA
JOR Spine; 2022 Mar; 5(1):e1187. PubMed ID: 35386760
[TBL] [Abstract][Full Text] [Related]
33. Advances and Prospects in Biomaterials for Intervertebral Disk Regeneration.
Li C; Bai Q; Lai Y; Tian J; Li J; Sun X; Zhao Y
Front Bioeng Biotechnol; 2021; 9():766087. PubMed ID: 34746112
[TBL] [Abstract][Full Text] [Related]
34. Decellularized Disc Hydrogels for hBMSCs tissue-specific differentiation and tissue regeneration.
Peng Y; Qing X; Lin H; Huang D; Li J; Tian S; Liu S; Lv X; Ma K; Li R; Rao Z; Bai Y; Chen S; Lei M; Quan D; Shao Z
Bioact Mater; 2021 Oct; 6(10):3541-3556. PubMed ID: 33842740
[TBL] [Abstract][Full Text] [Related]
35. Extracellular matrix grafts: From preparation to application (Review).
Jiang Y; Li R; Han C; Huang L
Int J Mol Med; 2021 Feb; 47(2):463-474. PubMed ID: 33416123
[TBL] [Abstract][Full Text] [Related]
36. Decellularized Intervertebral Discs: A Potential Replacement for Degenerate Human Discs.
Norbertczak HT; Ingham E; Fermor HL; Wilcox RK
Tissue Eng Part C Methods; 2020 Nov; 26(11):565-576. PubMed ID: 33050844
[TBL] [Abstract][Full Text] [Related]
37. Extracellular Matrix From Decellularized Wharton's Jelly Improves the Behavior of Cells From Degenerated Intervertebral Disc.
Penolazzi L; Pozzobon M; Bergamin LS; D'Agostino S; Francescato R; Bonaccorsi G; De Bonis P; Cavallo M; Lambertini E; Piva R
Front Bioeng Biotechnol; 2020; 8():262. PubMed ID: 32292779
[TBL] [Abstract][Full Text] [Related]
38. Biomaterials-Induced Stem Cells Specific Differentiation Into Intervertebral Disc Lineage Cells.
Peng Y; Huang D; Liu S; Li J; Qing X; Shao Z
Front Bioeng Biotechnol; 2020; 8():56. PubMed ID: 32117935
[TBL] [Abstract][Full Text] [Related]
39. Decellularization and characterization of a whole intervertebral disk xenograft scaffold.
Hensley A; Rames J; Casler V; Rood C; Walters J; Fernandez C; Gill S; Mercuri JJ
J Biomed Mater Res A; 2018 Sep; 106(9):2412-2423. PubMed ID: 29673061
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
